These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Gastroesophageal reflux: diagnostics and therapy of a widespread disease]. Hellmig S; Fölsch UR Med Klin (Munich); 2007 May; 102(5):373-80; quiz 381-2. PubMed ID: 17497088 [No Abstract] [Full Text] [Related]
43. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis. McKenna CJ; Mills JG; Goodwin C; Wood JR Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711 [TBL] [Abstract][Full Text] [Related]
44. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis. Harris RA; Kuppermann M; Richter JE Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748 [TBL] [Abstract][Full Text] [Related]
48. Reflux esophagitis in infants and children: a report from the Working Group on Gastro-Oesophageal Reflux Disease of the European Society of Paediatric Gastroenterology and Nutrition. Vandenplas Y J Pediatr Gastroenterol Nutr; 1994 May; 18(4):413-22. PubMed ID: 7915307 [TBL] [Abstract][Full Text] [Related]
49. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD. Katz PO Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654 [TBL] [Abstract][Full Text] [Related]
50. Roxithromycin in the eradication of Helicobacter pylori. Goh KL; Chuah SY; Azian M; Parasakthi N; Peh SC; Wong NW; Lo YL; Ong KK Am J Gastroenterol; 1994 Nov; 89(11):2099-100. PubMed ID: 7942758 [No Abstract] [Full Text] [Related]
51. The histamine H2 receptor antagonist lafutidine in Japanese patients with non-erosive reflux disease. Inamori M; Iida H; Hosono K; Endo H; Sakamoto Y; Takahashi H; Koide T; Tokoro C; Goto A; Abe Y; Hiratsuka N; Nakajima A; Fujita M Hepatogastroenterology; 2010; 57(104):1430-4. PubMed ID: 21443098 [TBL] [Abstract][Full Text] [Related]
52. [25 years of gastric acid blockers]. Lamers CB Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749 [TBL] [Abstract][Full Text] [Related]
53. Suppression of gastric acidity in horses. Murray MJ J Am Vet Med Assoc; 1997 Jul; 211(1):37-40. PubMed ID: 9215408 [No Abstract] [Full Text] [Related]
54. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer. Florent C Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399 [TBL] [Abstract][Full Text] [Related]
55. Long-term management of gastroesophageal reflux disease and its complications. Richter JE Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624 [TBL] [Abstract][Full Text] [Related]
56. [Is long-term acid suppression dangerous in existing Helicobacter pylori infection?]. Katsoulis S; Fölsch UR Z Gastroenterol; 1997 Sep; 35(9):891-4. PubMed ID: 9432821 [No Abstract] [Full Text] [Related]
57. Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis. Sekiguchi T; Nishioka T; Matsuzaki T; Sugiyama M; Kusano M; Horikoshi T; Toki M; Ohwada T; Kobayashi S Gastroenterol Jpn; 1991 Apr; 26(2):137-44. PubMed ID: 2040397 [TBL] [Abstract][Full Text] [Related]
58. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report]. Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780 [TBL] [Abstract][Full Text] [Related]
59. Treatment of reflux esophagitis with histamine H2-receptor antagonists. Kishi S; Tsuzi Y; Matsumura M; Kakutani A; Ito S; Mori H Tokushima J Exp Med; 1985 Dec; 32(3-4):65-70. PubMed ID: 2875547 [No Abstract] [Full Text] [Related]
60. The medical management of gastro-oesophageal reflux. Drug Ther Bull; 1996 Jan; 34(1):1-4. PubMed ID: 8746191 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]